Earnings Call · Q4 FY2022·2023-03-16

Q4 22EPS -14.02%·Rev n/aQ3 22EPS +0.88%·Rev n/aQ2 22EPS +11.28%·Rev n/aQ1 22EPS 0.00%·Rev n/a⚠ consensus missing

UroGen Pharma Ltd. URGN

Vincent Perrone — Chief Executive Officer

Liz Barrett — President and Chief Executive Officer

Mark Schoenberg — Chief Medical Officer

Jeff Bova — Chief Commercial Officer

Don Kim — Chief Financial Officer

+2.3%1d on move date+2.1% vs SPY3d+0.1%5d+8.1%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more URGN calls or request research access.

More URGN calls Browse calls Request research access